Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Stomach Neoplasms 16Carcinoma, Non-Small-Cell Lung 13Neoplasms 9Colorectal Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 5Breast Neoplasms 5Adenocarcinoma 5Neoplasm Metastasis 4Lung Neoplasms 4Carcinoma, Renal Cell 4Urethral Neoplasms 3Rectal Neoplasms 3Liver Neoplasms 3Esophageal Neoplasms 3Urinary Bladder Neoplasms 2Ureteral Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Malignant Solid Tumor 2Carcinoma, Transitional Cell 2Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Solid Tumor 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Ovarian Neoplasms 1Non-small Cell Lung Cancer Metastatic 1

Interventions

Carboplatin 87Paclitaxel 77Bevacizumab 38Topotecan 23liposomal doxorubicin 22Gemcitabine 22Taxes 21Cisplatin 17Drug Therapy 14Docetaxel 14Cyclophosphamide 14pembrolizumab 13Immunoglobulin G 12Disulfides 12veliparib 8rucaparib 8mirvetuximab soravtansine 8niraparib 7Albumin-Bound Paclitaxel 7sargramostim 6Filgrastim 6Erlotinib Hydrochloride 6Doxorubicin 6pazopanib 5Granulocyte-Macrophage Colony-Stimulating Factor 5Chemotherapy, Adjuvant 5CP protocol 5trebananib 4temsirolimus 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × Ramucirumab × Clear all
NCT00721162 2019-09-26

Study of Ramucirumab in Ovarian Cancer

Eli Lilly and Company

Phase 2 Completed
60 enrolled 14 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡